ICICI Prudential Life Insurance
Key Fundamentals
MidcapLife InsuranceInsurancePrice-based figures as of 23 Oct 2026, 15:56 IST · EPS basis: Consolidated · TTM
Tapetide Score
Data-driven rating, 0–100. How it works →
v2.0.0
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company is expected to give good quarter
Weaknesses
4- Stock is trading at 4.66 times its book value
- The company has delivered a poor sales growth of -5.30% over past five years.
- Tax rate seems low
- Company has a low return on equity of 8.75% over last 3 years.
Technical Indicators
Oscillators
Bullish
Overall
Bearish
Moving Averages
Bearish
30 of 33 analysts rate Buy, 3 Hold, 0 Sell.
Updated 23 Oct 2026
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin -24% · Mar 2026
AI Analysis — Bull vs Bear
ICICI Prudential Life Insurance trades at ₹422.2 as of 2026-10-23 with a market cap of ₹61,271 Cr, a trailing PE of 38.07x, and a price-to-book of 4.56x. The stock sits near its 52-week low of ₹413.4, down roughly 40% from its 52-week high of ₹706.8, while TTM profit growth of 36% contrasts sharply with a TTM sales decline of -10%.
- Strong TTM profit growth of 36% indicates improving underwriting profitability and cost discipline despite top-line pressures
- 3-year compounded profit CAGR of 26% demonstrates a sustained earnings expansion trend over a meaningful period
- Last-year ROE of 13% marks a notable improvement over the 3-year average of 9% and 5-year average of 9%, suggesting improving capital efficiency
- Conservative balance sheet with a debt-to-equity ratio of just 0.19x provides financial flexibility and limits solvency risk
- Stock is trading at ₹422.2, only 2.1% above its 52-week low of ₹413.4, which historically can indicate most of the negative sentiment is already reflected in the price
- Company is expected to deliver a good upcoming quarter, which could act as a near-term catalyst for sentiment improvement
- 10-year compounded sales CAGR of 12% shows the company has a track record of long-term top-line growth despite recent weakness
- TTM sales growth is -10%, pointing to a meaningful contraction in premium income or top-line revenue in the most recent period
- 5-year compounded sales CAGR of -5% signals a prolonged structural struggle in growing the business, not just a one-off dip
- Trailing PE of 38.07x is elevated for a company with negative recent sales growth, suggesting limited margin of safety in the valuation
- Price-to-book of 4.56x is rich, especially given a 3-year average ROE of only 9%, implying the market is pricing in returns the company has not consistently delivered
- Stock price CAGR of -27% over 1 year, -6% over 3 years, and -7% over 5 years reflects persistent long-term wealth destruction for shareholders
- 3-year average ROE of approximately 9% is below the cost of equity for most insurance businesses, raising questions about sustainable value creation
- Dividend yield of just 0.38% offers negligible income support to investors during periods of capital depreciation
- 10-year compounded profit CAGR of 0% means that despite recent profit surges, long-term earnings have effectively stagnated over a decade
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- ₹591Cr IT rectification order Oct 20
ICICI Life received a ₹591 crore incremental tax and interest demand from the IT Dept for AY 2023. The company has filed an appeal.
- ₹279Cr tax demand for AY24 Oct 15
A separate rectification order for AY24 demands ₹278.9 crore. Combined with the AY23 order, total tax disputes stand at ~₹870 crore.
- H1FY27 VNB up 22.3% Oct 21
Value of New Business rose 22.3% YoY to ₹1,283 crore in H1FY27. Protection mix improved to 23.4%, driving margin expansion.
- Q2FY27 net profit up 25% Oct 15
Net profit grew 25% YoY to ₹374.2 crore in Q2FY27 with EPS of ₹2.58 vs ₹2.07. Gross premium income reached ₹14,254.6 crore and debt-equity ratio improved to 0.18.
- CEO Bagchi resigns, successor named Oct 2
MD & CEO Anup Bagchi resigns effective Oct 13, 2026. Sidharatha Mishra appointed COO and incoming MD & CEO, subject to IRDAI approval.
- H1FY27 earnings call scheduled Oct 7
ICICI Life hosted an earnings conference call on Oct 13, 2026 at 3:30 pm IST to discuss H1FY27 results.
TL;DR: ICICI Prudential Life is delivering strong operating performance with VNB up 22.3% and net profit up 25% YoY, supported by an improving protection mix and better margins. Key risks include ~₹870 crore in cumulative tax demands across AY23 and AY24, both under appeal, and a leadership transition with a new MD & CEO awaiting IRDAI approval. The underlying business trend is improving, but resolution of the tax disputes and a smooth CEO handover will be important near-term monitorables.
Analyst Forecasts
Quarterly Results
| Particulars | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10,984 | 23,384 | 17,388 | 26,430 | 22,482 | 25,396 | 25,158 | 4,536 | 15,687 | 25,401 | 11,936 | 22,834 | 3,185 |
| Expenses | 11,400 | 23,663 | 17,682 | 26,584 | 22,760 | 25,362 | 24,839 | 4,295 | 15,272 | 25,188 | 11,955 | 22,093 | 3,940 |
| Operating Profit | -416 | -280 | -293 | -155 | -278 | 34 | 319 | 241 | 415 | 213 | -19 | 741 | -754 |
| OPM % | -3.8% | -1.2% | -1.7% | -0.6% | -1.2% | 0.1% | 1.3% | 5% | 2.6% | 0.8% | -0.2% | 3.2% | -24% |
| Other Income | 780 | 496 | 570 | 420 | 549 | 237 | -17 | 169 | 183 | 177 | 408 | -243 | 1,036 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 364 | 216 | 276 | 265 | 270 | 271 | 302 | 410 | 598 | 390 | 389 | 498 | 281 |
| Tax % | 35% | 5% | 12% | 14% | 36% | 17% | 17% | 21% | 36% | 23% | 24% | 22% | -122% |
| Net Profit | 235 | 206 | 244 | 227 | 174 | 224 | 251 | 325 | 385 | 301 | 296 | 387 | 624 |
| EPS (₹) | 1.64 | 1.43 | 1.69 | 1.58 | 1.21 | 1.56 | 1.74 | 2.25 | 2.67 | 2.08 | 2.04 | 2.67 | 4.3 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 34,453 | 20,849 | 37,816 | 38,832 | 41,463 | 21,025 | 83,182 | 63,564 | 50,478 | 89,683 | 70,778 | 63,357 |
| Expenses | 32,798 | 19,008 | 36,010 | 37,062 | 40,922 | 21,344 | 83,572 | 65,728 | 52,235 | 90,580 | 69,321 | 62,050 |
| Operating Profit | 1,655 | 1,842 | 1,806 | 1,771 | 541 | -319 | -390 | -2,163 | -1,757 | -897 | 1,457 | 1,307 |
| OPM % | 4.8% | 9% | 4.8% | 4.6% | 1.3% | -1.5% | -0.5% | -3.4% | -3.5% | -1% | 2.1% | 2.1% |
| Other Income | 43 | 0 | 130 | 132 | 813 | 1,578 | 1,669 | 3,191 | 2,925 | 2,039 | 258 | 397 |
| Interest | 17 | 0 | 15 | 20 | 23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 40 | 0 | 58 | 44 | 57 | 61 | 60 | 67 | 84 | 113 | 134 | 145 |
| PBT | 1,642 | 1,842 | 1,863 | 1,839 | 1,274 | 1,198 | 1,219 | 961 | 1,085 | 1,028 | 1,582 | 1,559 |
| Tax % | 0% | 10% | 10% | 12% | 11% | 11% | 22% | 21% | 25% | 17% | 25% | -3% |
| Net Profit | 1,640 | 1,650 | 1,682 | 1,619 | 1,139 | 1,067 | 956 | 759 | 813 | 851 | 1,186 | 1,608 |
| EPS (₹) | 11.46 | 11.52 | 11.72 | 11.28 | 7.93 | 7.43 | 6.66 | 5.28 | 5.65 | 5.9 | 8.2 | 11.09 |
| Div. Payout % | 51% | 73% | 63% | 59% | 40% | 11% | 30% | 10% | 11% | 10% | 10% | 15% |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1,432 | 1,432 | 1,435 | 1,436 | 1,436 | 1,436 | 1,436 | 1,437 | 1,439 | 1,441 | 1,445 | 1,449 |
| Reserves | 3,833 | 3,891 | 4,971 | 5,138 | 5,435 | 5,777 | 7,673 | 7,721 | 8,651 | 9,564 | 10,488 | 12,182 |
| Borrowings | 0 | 1,029 | 0 | 0 | 0 | 0 | 1,200 | 1,200 | 1,200 | 1,200 | 2,600 | 2,595 |
| Other Liabilities | 95,951 | 98,413 | 1,18,335 | 1,35,245 | 1,56,215 | 1,48,818 | 2,06,911 | 2,34,079 | 2,44,562 | 2,86,796 | 2,99,705 | 3,03,509 |
| Total Liabilities | 1,01,215 | 1,04,765 | 1,24,741 | 1,41,819 | 1,63,086 | 1,56,031 | 2,17,220 | 2,44,437 | 2,55,851 | 2,99,001 | 3,14,239 | 3,19,735 |
| Fixed Assets | 209 | 212 | 207 | 404 | 463 | 932 | 911 | 433 | 479 | 1,168 | 1,315 | 1,378 |
| CWIP | 6 | 7 | 7 | 18 | 13 | 20 | 22 | 54 | 117 | 49 | 36 | 43 |
| Investments | 99,491 | 1,03,024 | 1,21,581 | 1,38,537 | 1,59,003 | 1,50,776 | 2,11,727 | 2,38,101 | 2,48,216 | 2,89,230 | 3,03,475 | 3,07,369 |
| Other Assets | 1,509 | 1,522 | 2,946 | 2,859 | 3,607 | 4,303 | 4,560 | 5,848 | 7,039 | 8,553 | 9,412 | 10,944 |
| Total Assets | 1,01,215 | 1,04,765 | 1,24,741 | 1,41,819 | 1,63,086 | 1,56,031 | 2,17,220 | 2,44,437 | 2,55,851 | 2,99,001 | 3,14,239 | 3,19,735 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 523 | 3,634 | 4,130 | 5,690 | 11,377 | 8,596 | 7,314 | 1,831 | 89 | -7,315 | -9,408 | -5,355 |
| Investing | -1,822 | 27 | -696 | -5,389 | -7,559 | -10,797 | -5,084 | -816 | -1,145 | 7,420 | 6,869 | 7,571 |
| Financing | -966 | -1,442 | -994 | -1,188 | -843 | -405 | 1,205 | -319 | -112 | -88 | 1,422 | -171 |
| Net Cash Flow | -2,264 | 2,219 | 2,439 | -887 | 2,975 | -2,606 | 3,434 | 696 | -1,168 | 17 | -1,116 | 2,045 |
| Free Cash Flow | 471 | 3,583 | 4,078 | 5,622 | 11,270 | -1,12,909 | 7,279 | 1,736 | -105 | -7,550 | -9,663 | -5,473 |
| CFO/EBITDA | 32 | 208 | 229 | 321 | 2,103 | -2,710 | -1,930 | -95 | -21 | 790 | -623 | -365 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Conversion Cycle | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital Days | -10 | -16 | -2 | -9 | -9 | -5 | -2 | -6 | -5 | 2 | 3 | -1 |
| ROCE % | 34% | 32% | 29% | 29% | 16% | 17% | 14% | 9% | 10% | 3% | 12% | 10% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view ICICI Prudential Life Insurance insights
48 extracted metrics + investor summaries across FY11–FY27.
Documents
Frequently Asked Questions about ICICI Prudential Life Insurance
What does ICICI Prudential Life Insurance Company Ltd do?
Where is ICICI Prudential Life Insurance Company Ltd (ICICILIFE) listed?
Which sector does ICICI Prudential Life Insurance Company Ltd belong to?
What is the market capitalisation of ICICI Prudential Life Insurance Company Ltd?
What is the PE ratio of ICICI Prudential Life Insurance Company Ltd?
What is the 52-week high and low of ICICI Prudential Life Insurance Company Ltd?
Does ICICI Prudential Life Insurance Company Ltd pay dividends?
What is the Return on Equity (ROE) of ICICI Prudential Life Insurance Company Ltd?
Company Information
ICICI Prudential Life Insurance Company Ltd carries on business of providing life insurance, pensions and health insurance products to individuals and groups. The business is conducted in participating, non-participating and unit linked lines of business. These products are distributed through individual agents, corporate agents, banks, brokers, sales force and company's website.[1] It is promoted by ICICI Bank and Prudential Corporation :- ICICI Bank (51% stake)[2] - The company is a part of ICICI Bank Ltd which is the 2nd largest private bank in India. It offers a diversified range of products and services to retail, SME and corporate customers.[3] Prudential Plc (22% stake) - It is a British multinational insurance company based in London, England. It is the largest UK life insurer in Asia with presence in India, China, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines and other Asian countries. It is also present in African subcontinent in Nigeria, Ghana, Togo and other countries.[4]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/ICICIPRULI.md for ICICI Prudential Life Insurance Company Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.